LRMR · NASDAQ · Biotechnology

Larimar Therapeutics (LRMR)

Develops nomlabofusp to deliver frataxin in Friedreich's ataxia.

$3.74
vs last close−0.08 (−2.23%)

13F · 13D/G · Form 4

Institutions≈ 92.16%95.74M shares
171 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail
Insiders1.40%1.46M shares
7 holders · as of Jul 8, 2026
Other≈ 6.44%6.68M shares
remainder

103.88M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

13F · 13D/G · Form 4

HolderStakeSharesDate
Deerfield Management Company, L.P. (Series C)Institution
34.28%35.61Mas of Jun 30, 2026
Blue Owl Capital Holdings LPInstitution
8.82%9.16Mas of Jun 30, 2026
BlackRock, Inc.Institution
5.47%5.68Mas of Jun 30, 2026
Defilade Capital Management, L.P.Institution
3.53%3.67Mas of Jun 30, 2026
Driehaus Capital Management LLCInstitution
3.05%3.16Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
2.86%2.97Mas of Jun 30, 2026
RTW Investments, LPInstitution
2.47%2.57Mas of Jun 30, 2026
AQR Capital Management LLCInstitution
2.28%2.37Mas of Jun 30, 2026
Marshall Wace, LLPInstitution
1.94%2.01Mas of Jun 30, 2026
Dafna Capital Management LLCInstitution
1.93%2.01Mas of Jun 30, 2026
Goldman Sachs Group IncInstitution
1.69%1.75Mas of Jun 30, 2026
Geode Capital Management, LLCInstitution
1.62%1.68Mas of Jun 30, 2026
Qube Research & Technologies LtdInstitution
1.58%1.64Mas of Jun 30, 2026
Citadel Advisors LLCInstitution
1.40%1.46Mas of Jun 30, 2026
State Street CorpInstitution
1.36%1.41Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
1.35%1.40Mas of Jun 30, 2026
Woodline Partners LPInstitution
1.35%1.40Mas of Jun 30, 2026
Millennium Management LLCInstitution
1.28%1.33Mas of Jun 30, 2026
Dimensional Fund Advisors LPInstitution
0.93%961,083as of Jun 30, 2026
FMR LLCInstitution
0.90%937,368as of Jun 30, 2026
Sphera Funds Management Ltd.Institution
0.89%926,004as of Jun 30, 2026
Nuveen, LLCInstitution
0.86%895,304as of Jun 30, 2026
Thomas Edward HamiltonInsiderdirector
0.69%714,798filed Jul 8, 2026
Alyeska Investment Group, L.P.Institution
0.59%617,211as of Jun 30, 2026
Northern Trust CorpInstitution
0.53%550,266as of Jun 30, 2026

13F, as of Jun 30, 2026

171 holders · 95.74M shares · 34 new positions · 103 increased · 39 reduced · 31 closed

HolderShares% outstandingChg q/qFiled
Deerfield Management Company, L.P. (Series C)35.61M34.28%0Aug 14, 2026
Blue Owl Capital Holdings LP9.16M8.82%+2.04MAug 11, 2026
BlackRock, Inc.5.68M5.47%+1.93MAug 7, 2026
Defilade Capital Management, L.P.3.67M3.53%+3.67MnewAug 14, 2026
Driehaus Capital Management LLC3.16M3.05%+229.0KAug 14, 2026
Vanguard Capital Management LLC2.97M2.86%+108.6KAug 13, 2026
RTW Investments, LP2.57M2.47%+1.07MAug 14, 2026
AQR Capital Management LLC2.37M2.28%+1.55MAug 14, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Deerfield Management Company, L.P.incl. Deerfield Partners, L.P., Deerfield Healthcare Innovations Fund, L.P. +7 more34.41%35.67M13DMar 2, 2026
Blue Owl Capital Holdings LP9.99%10.74M13GMay 14, 2026
Goldman Sachs & Co. LLCincl. The Goldman Sachs Group, Inc.7.00%4.49MNov 6, 2024

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jul 6, 2026
Thomas Edward Hamiltondirector
Purchase50,000$3.34714,798
Feb 27, 2026
Jeffrey W. Shermandirector
Purchase5,000$5.005,000
Feb 27, 2026
Frank E. Thomasdirector
Purchase5,000$5.007,000
Feb 27, 2026
Thomas Edward Hamiltondirector
Purchase100,000$5.00664,798
Feb 27, 2026
James E. Flynndirector, 10 percent owner, other: * Director by Deputization
Purchase · 4 lots5,000,000$5.0010,622,957

House and Senate disclosures

Not reported.